Triamcinolone acetonide

Author:Prof. Dr. med. Peter Altmeyer

Co-Autor:Dr. med. hans-werner momberger

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

Head tincture triamcinolone acetonide-containing 05%.; Hydrophilic triamcinolone acetonide cream 01% (NRF 11.38.); Triamcinolone acetonide hair alcohol 02% (nach ICHTHYOL); Triamcinolone acetonide ointment low in water (nach Gloor); Triamcinolone acetonide skin spirit 02% with salicylic acid 2% (NRF 11.39.)

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Moderately effective (class II) glucocorticoid halogenated with fluorine which is suitable as a topical agent for short-term skin therapy.

Half-lifeThis section has been translated automatically.

3-5 hours or 3 weeks (metabolites).

Pharmacodynamics (Effect)This section has been translated automatically.

Like other glucocorticoids, trimacinolone acetonide has anti-inflammatory, immunosuppressive, antipruriginous and antiproliferative effects.

IndicationThis section has been translated automatically.

Systemic glucocorticoid therapy. Topical for eczema, allergic reactions, psoriasis vulgaris.

Limited indicationThis section has been translated automatically.

Pregnancy.

Dosage and method of useThis section has been translated automatically.

  • Topical: Cream/Ointment/Spray/Lotion: Apply 1-2 times/day thinly to the affected skin areas.

    Remember!

    Duration of application max. 4 weeks!
  • Injection: 0,5-1 ml intrafocal, intraarticular, sublesional.

Standard concentrationThis section has been translated automatically.

Creams/ointments: 0.025-0.1%, solutions: 0.1%.

Undesirable effectsThis section has been translated automatically.

Side effects on triamcinolone acetonide are very rare. The DKG has tested triamcinolone acetonide 0.1% in Vasline so far. This application form is no longer available as a test substance in Germany. Therefore, a 1% concentration of triamcinolone acetonide in Vaseline is now (as of 2016) recommended.

ContraindicationThis section has been translated automatically.

Topical application > 4 weeks.

Recipe(s)This section has been translated automatically.

PreparationsThis section has been translated automatically.

Delphicort, Volon, Volonimat, Triamgalen, Corticoid-ratiopharm, Polcortolon N Spray

Note(s)This section has been translated automatically.

  • The optimum pH stability is pH7 and harmonizes with that of Clotrimazole, for example. Triamcinolone acetonide is insoluble in water and moderately soluble in ethanol (5 in 100). Alkaline and acidic active ingredients and auxiliaries lead to hydrolytic cleavage (acetonide residue is split off = 90% loss of effectiveness). Combinations with (weakly basic) zinc oxide lead to slow hydrolytic and oxidative decomposition (shelf life must be limited to 4 months).
  • For the treatment of skin diseases at difficult locations the active ingredient is available as a spray (Polcortolon N Spray).
  • According to recent extensive studies, intramuscular administration can no longer be considered obsolete. It is a properly performed alternative for severe inflammatory skin diseases or allergies (Østergaard MS et al. 2005).

LiteratureThis section has been translated automatically.

  1. Geier J et al (2016) News on the epicutaneous test series of the German Contact Allergy Group. Dermatology at work and in the environment 64: 70-75
  2. Østergaard MS (2005) Hay fever and a single intramuscular injection of corticosteroid: A systematic review. Primary Care Respiratory Journal 14:124-30

Authors

Last updated on: 29.10.2020